Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

EntreMed Files for China Arm of its Sarcoma Clinical Trial

06:52 EDT 28 Jun 2013 | ChinaBio Today

EntreMed, a US pharma with a Beijing subsidiary, has filed an application with the CFDA to conduct a clinical trial in China for ENMD-2076, a novel drug that is EntreMed’s lead drug candidate. Currently, the drug is undergoing a Phase II trial...

Original Article: EntreMed Files for China Arm of its Sarcoma Clinical Trial

NEXT ARTICLE

More From BioPortfolio on "EntreMed Files for China Arm of its Sarcoma Clinical Trial"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story